Annual Current Liabilities
$19.05 M
+$3.46 M+22.22%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual total current liabilities is $19.05 million, with the most recent change of +$3.46 million (+22.22%) on December 31, 2023.
- During the last 3 years, NRXP annual current liabilities has fallen by -$27.12 million (-58.74%).
- NRXP annual current liabilities is now -58.74% below its all-time high of $46.16 million, reached on December 31, 2020.
Performance
NRXP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$20.30 M
-$3.36 M-14.19%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly total current liabilities is $20.30 million, with the most recent change of -$3.36 million (-14.19%) on September 30, 2024.
- Over the past year, NRXP quarterly current liabilities has increased by +$1.44 million (+7.65%).
- NRXP quarterly current liabilities is now -56.03% below its all-time high of $46.16 million, reached on December 31, 2020.
Performance
NRXP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NRXP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.2% | +7.7% |
| 3 y3 years | -58.7% | +152.4% |
| 5 y5 years | -58.7% | - |
NRXP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.8% | -14.2% | +186.7% |
| 5 y | 5-year | -58.7% | +59.8% | -56.0% | +186.7% |
| alltime | all time | -58.7% | +59.8% | -56.0% | +186.7% |
NRx Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.30 M(-14.2%) |
| Jun 2024 | - | $23.66 M(+25.4%) |
| Mar 2024 | - | $18.86 M(-1.0%) |
| Dec 2023 | $19.05 M(+22.2%) | $19.05 M(-1.4%) |
| Sep 2023 | - | $19.33 M(-14.5%) |
| Jun 2023 | - | $22.62 M(+2.5%) |
| Mar 2023 | - | $22.06 M(+41.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $15.59 M(+30.7%) | $15.59 M(+93.8%) |
| Sep 2022 | - | $8.04 M(+13.6%) |
| Jun 2022 | - | $7.08 M(-40.6%) |
| Mar 2022 | - | $11.91 M(-0.1%) |
| Dec 2021 | $11.92 M(-74.2%) | $11.92 M(-67.1%) |
| Sep 2021 | - | $36.28 M(+2.3%) |
| Jun 2021 | - | $35.47 M(-23.2%) |
| Dec 2020 | $46.16 M | $46.16 M |
FAQ
- What is NRx Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual current liabilities year-on-year change?
- What is NRx Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly current liabilities year-on-year change?
What is NRx Pharmaceuticals annual total current liabilities?
The current annual current liabilities of NRXP is $19.05 M
What is the all time high annual current liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total current liabilities is $46.16 M
What is NRx Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, NRXP annual total current liabilities has changed by +$3.46 M (+22.22%)
What is NRx Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of NRXP is $20.30 M
What is the all time high quarterly current liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total current liabilities is $46.16 M
What is NRx Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, NRXP quarterly total current liabilities has changed by +$1.44 M (+7.65%)